Tumour Inhomogeneities on Magnetic Resonance Imaging, A New Factor with Prognostic Information in Non-Hodgkin's Lymphomas

References

• Horning S. J. Low-grade lymphoma 1993; 1993, State of the art. Ann. of Oncol.; 5:(suppl. 2), 23–27
   Google Scholar
• Coiffier B. Fourteen years of high-dose CHOP (ACVB regimen) Preliminary conclusions about the treatment of aggressive-lymphoma patients. Ann. of Oncol. 1995; 6: 211–217
   PubMed Web of Science ®Google Scholar
• Hagberg H., Glimelius B., Sundström C. Radiation therapy of non-Hodgkin's lymphoma stage I and II. Acta Radiol 1982; 21: 145–150
   Web of Science ®Google Scholar
• Nyman R., Rehn S., Glimelius B., Hagberg H., Hemmingsson A., Lindgren P. G., Magnusson A. Magnetic resonance imaging, chest radiography, computed tomography and ultrasonography in malignant lymphoma. Acta Radiol. 1987; 28: 1–11
   Web of Science ®Google Scholar
• Nyman R., Rehn S., Ericsson A., Glimelius B., Hagberg H., Hemmingsson A., Sundström C. An attempt to characterize malignant lymphoma in spleen, liver and lymph nodes with magnetic resonance imaging. Acta Radiol. Diagn. 1987; 28: 527–533
   Google Scholar
• Ebner F., Kressel H. Y., Mintz M. C., Carlson J. A., Cohen E. K., Schiebler M., Gefter W., Axel L. Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5. T. Radiology 1988; 166, 333–340
   Google Scholar
• Rehn S. M., Nyman R. S., Glimelius B. L. G., Hagberg H. E., Sundström J. C. Magnetic resonance imaging for predicting prognostic grade in non-Hodgkin lymphomas. Radiology 1990; 176: 249–253
   PubMed Web of Science ®Google Scholar
• Rehn S., Sperber G., Nyman R., Glimelius B., Hagberg H., Hemmingsson A. Quantification of inhomogenieties in malignancy grading of non-Hodgkin lymphomas with MR imaging. Acta Radiol. Diagn. 1993; 34: 3–9
   Google Scholar
• Stansfeld A., Diebold J., Kapanci Y., Kelényi G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundström C., van Unnik J., Wright D. Updated Kiel classification for lymphomas. Lancet 1988; 292–293
   PubMed Web of Science ®Google Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. M. Report of the Committee in Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Shipp M. A., Harrington D. P., Anderson J. R., Armitage J. O., Bonnadonna G., Brittinger G., Cabanillas F., Canellos G. P., Coiffier B., Connors J. M., Cowan R. A., Crowther D., Dahlberg S., Engelhard M., Fisher R. I., Gisselbrecht C., Horning S. J., Lepage E., Lister T. A., Meerwaldt J. H., Montserrat E., Nissen N. I., Oken M. M., Tondini C., Velasquez W. A., Yeap B. Y. A predictive model for aggressive non-Hodgkin's lymphoma. New Engl. J. Med. 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Hagberg H., Lindemalm C., Cavallin-Ståhl E. for the Swedish Lymphoma Study Group. CHOP versus CHOP-M in the treatment of high-grade malignant non-Hodgkins lymphomas in adults: A Swedish national randomized study. Proc. ASCO 1988; 7: 243
   Google Scholar
• Klimo P., Connors J. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann. Intern. Med. 1985; 102: 596–602
   PubMed Web of Science ®Google Scholar
• Kimby E., Björkholm M., Gahrton G., Glimelius B., Hagberg H., Johansson B., Johansson H., Juliusson G., Järnmark M., Löfvenberg E., Killander A., Lerner R., Lindemalm C., Pettersson U., Robért K. H., Simonsson B., Stalfelt A-M., Sundström C., Svedmyr E., Udén A-M., Wadman B., Wahlin A., Öst A., Mellstedt H. Chlorambucil/Prednisolon vs. CHOP in symptomatic lowgade non-Hodgkin's lymphomas: A randomized trial from the Lymphoma Group of Central Sweden. Ann. of Oncol. 1994; 5, (suppl. 2), 67–71
   PubMed Web of Science ®Google Scholar
• Costa A., Bonadonna G., Villa E., Valagussa P., Silvestrini R. Labelling index as a prognostic marker in non-Hodgkin's lymphomas. J. nat. Cancer Inst. 1981; 66: 1–5
   PubMed Web of Science ®Google Scholar
• Donhuijsen K. Mitosis in non-Hodgkin's lymphomas, frequency and prognostic relevance. Path. Res. Pract. 1987; 182: 352–357
   PubMed Web of Science ®Google Scholar
• Rehn S., Glimelius B., Sundström C. A comparative study of proliferation-associated parameters in B-cell non-Hodgkin lymphomas. Hematol. Oncol. 1991; 9: 287–298
   PubMed Web of Science ®Google Scholar
• Overgaard J., Horsman M. R. Overcoming hypoxic cell radio-resistance. Basic clinical radiobiology, G. G. Steel. Edward Arnold, London: PA 1993; 163–172
   Google Scholar
• Russel D., Rubinstein L. Pathology of tumours of the nervous system, 5th ed. Edward Arnold, London: PA 1989; 219–247
   Google Scholar